| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | hypotaurine monooxygenase activity | 4.51e-05 | 5 | 43 | 2 | GO:0047822 | |
| GeneOntologyMolecularFunction | cytoskeleton-nuclear membrane anchor activity | 4.51e-05 | 5 | 43 | 2 | GO:0140444 | |
| GeneOntologyMolecularFunction | N,N-dimethylaniline monooxygenase activity | 6.76e-05 | 6 | 43 | 2 | GO:0004499 | |
| GeneOntologyMolecularFunction | protein-membrane adaptor activity | 1.24e-04 | 45 | 43 | 3 | GO:0043495 | |
| GeneOntologyMolecularFunction | NADP binding | 3.22e-04 | 62 | 43 | 3 | GO:0050661 | |
| GeneOntologyCellularComponent | microtubule organizing center attachment site | 1.23e-06 | 11 | 42 | 3 | GO:0034992 | |
| GeneOntologyCellularComponent | meiotic nuclear membrane microtubule tethering complex | 1.23e-06 | 11 | 42 | 3 | GO:0034993 | |
| GeneOntologyCellularComponent | nuclear membrane protein complex | 1.23e-06 | 11 | 42 | 3 | GO:0106083 | |
| GeneOntologyCellularComponent | nuclear membrane microtubule tethering complex | 1.23e-06 | 11 | 42 | 3 | GO:0106094 | |
| Domain | Spectrin/alpha-actinin | 8.36e-07 | 32 | 43 | 4 | IPR018159 | |
| Domain | SPEC | 8.36e-07 | 32 | 43 | 4 | SM00150 | |
| Domain | Envoplakin | 5.18e-06 | 2 | 43 | 2 | IPR030460 | |
| Domain | KASH | 3.10e-05 | 4 | 43 | 2 | PF10541 | |
| Domain | KASH | 3.10e-05 | 4 | 43 | 2 | IPR012315 | |
| Domain | KASH | 3.10e-05 | 4 | 43 | 2 | SM01249 | |
| Domain | KASH | 3.10e-05 | 4 | 43 | 2 | PS51049 | |
| Domain | Spectrin_repeat | 3.98e-05 | 29 | 43 | 3 | IPR002017 | |
| Domain | FMO-like | 5.15e-05 | 5 | 43 | 2 | PF00743 | |
| Domain | Flavin_mOase-like | 5.15e-05 | 5 | 43 | 2 | IPR020946 | |
| Domain | Flavin_mOase | 5.15e-05 | 5 | 43 | 2 | IPR000960 | |
| Domain | DiMe-aniline_mOase | 5.15e-05 | 5 | 43 | 2 | IPR012143 | |
| Domain | Actinin_actin-bd_CS | 1.27e-03 | 23 | 43 | 2 | IPR001589 | |
| Domain | ACTININ_2 | 1.27e-03 | 23 | 43 | 2 | PS00020 | |
| Domain | ACTININ_1 | 1.27e-03 | 23 | 43 | 2 | PS00019 | |
| Domain | Spectrin | 1.27e-03 | 23 | 43 | 2 | PF00435 | |
| Domain | - | 7.37e-03 | 56 | 43 | 2 | 3.50.50.60 | |
| Domain | FAD/NAD-binding_dom | 7.63e-03 | 57 | 43 | 2 | IPR023753 | |
| Pathway | WP_CATALYTIC_CYCLE_OF_MAMMALIAN_FLAVINCONTAINING_MONOOXYGENASES_FMOS | 5.96e-05 | 5 | 35 | 2 | M39449 | |
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 22768332 | ||
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 17761684 | ||
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 31578382 | ||
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 11792814 | ||
| Pubmed | Nesprin-1 and nesprin-2 regulate endothelial cell shape and migration. | 1.56e-06 | 2 | 44 | 2 | 24931616 | |
| Pubmed | Syne-1 and Syne-2 play crucial roles in myonuclear anchorage and motor neuron innervation. | 1.56e-06 | 2 | 44 | 2 | 17267447 | |
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 16247451 | ||
| Pubmed | Nesprins: tissue-specific expression of epsilon and other short isoforms. | 1.56e-06 | 2 | 44 | 2 | 24718612 | |
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 24586179 | ||
| Pubmed | 1.56e-06 | 2 | 44 | 2 | 15144220 | ||
| Pubmed | Evidence of a link between ubiquilin 2 and optineurin in amyotrophic lateral sclerosis. | 4.69e-06 | 3 | 44 | 2 | 25398946 | |
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 17462627 | ||
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 10878022 | ||
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 30381441 | ||
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 24792439 | ||
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 33472039 | ||
| Pubmed | Nesprins anchor kinesin-1 motors to the nucleus to drive nuclear distribution in muscle cells. | 4.69e-06 | 3 | 44 | 2 | 25516977 | |
| Pubmed | The inner nuclear membrane protein Sun1 mediates the anchorage of Nesprin-2 to the nuclear envelope. | 4.69e-06 | 3 | 44 | 2 | 16079285 | |
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 19262426 | ||
| Pubmed | 4.69e-06 | 3 | 44 | 2 | 12408964 | ||
| Pubmed | Mammalian sperm head formation involves different polarization of two novel LINC complexes. | 9.37e-06 | 4 | 44 | 2 | 20711465 | |
| Pubmed | 9.37e-06 | 4 | 44 | 2 | 19596800 | ||
| Pubmed | 9.37e-06 | 4 | 44 | 2 | 16648470 | ||
| Pubmed | LINC complexes mediate the positioning of cone photoreceptor nuclei in mouse retina. | 9.37e-06 | 4 | 44 | 2 | 23071752 | |
| Pubmed | Outer nuclear membrane protein Kuduk modulates the LINC complex and nuclear envelope architecture. | 9.37e-06 | 4 | 44 | 2 | 28716842 | |
| Pubmed | Quantitative analysis of FMO gene mRNA levels in human tissues. | 9.37e-06 | 4 | 44 | 2 | 16183778 | |
| Pubmed | The molecular biology of the flavin-containing monooxygenases of man. | 9.37e-06 | 4 | 44 | 2 | 7720101 | |
| Pubmed | Nesprins, but not sun proteins, switch isoforms at the nuclear envelope during muscle development. | 9.37e-06 | 4 | 44 | 2 | 20108321 | |
| Pubmed | 1.56e-05 | 5 | 44 | 2 | 8128486 | ||
| Pubmed | Flavin-Containing Monooxygenase 1 Catalyzes the Production of Taurine from Hypotaurine. | 1.56e-05 | 5 | 44 | 2 | 32156684 | |
| Pubmed | 1.56e-05 | 5 | 44 | 2 | 8311461 | ||
| Pubmed | Mechanism of cargo-directed Atg8 conjugation during selective autophagy. | 1.56e-05 | 5 | 44 | 2 | 27879200 | |
| Pubmed | 1.56e-05 | 5 | 44 | 2 | 18396275 | ||
| Pubmed | LINC complexes form by binding of three KASH peptides to domain interfaces of trimeric SUN proteins. | 1.56e-05 | 5 | 44 | 2 | 22632968 | |
| Pubmed | 1.56e-05 | 5 | 44 | 2 | 29133525 | ||
| Pubmed | 2.34e-05 | 6 | 44 | 2 | 14526201 | ||
| Pubmed | 2.34e-05 | 6 | 44 | 2 | 12527699 | ||
| Pubmed | Structural Analysis of Different LINC Complexes Reveals Distinct Binding Modes. | 2.34e-05 | 6 | 44 | 2 | 33058875 | |
| Pubmed | 2.34e-05 | 6 | 44 | 2 | 18827015 | ||
| Pubmed | Ubiquitin binding mediates the NF-kappaB inhibitory potential of ABIN proteins. | 3.27e-05 | 7 | 44 | 2 | 18212736 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 3.80e-05 | 1024 | 44 | 8 | 24711643 | |
| Pubmed | Nesprin 1α2 is essential for mouse postnatal viability and nuclear positioning in skeletal muscle. | 6.99e-05 | 10 | 44 | 2 | 28533284 | |
| Pubmed | Nuclear membrane proteins with potential disease links found by subtractive proteomics. | 6.99e-05 | 10 | 44 | 2 | 12958361 | |
| Pubmed | 8.18e-05 | 66 | 44 | 3 | 19898482 | ||
| Pubmed | Study of the common genetic background for rheumatoid arthritis and systemic lupus erythematosus. | 8.54e-05 | 11 | 44 | 2 | 21068098 | |
| Pubmed | 8.54e-05 | 11 | 44 | 2 | 22826121 | ||
| Pubmed | 1.21e-04 | 13 | 44 | 2 | 21177258 | ||
| Pubmed | 1.41e-04 | 14 | 44 | 2 | 28319114 | ||
| Pubmed | 1.41e-04 | 14 | 44 | 2 | 19874786 | ||
| Pubmed | 1.89e-04 | 225 | 44 | 4 | 12168954 | ||
| Pubmed | 2.36e-04 | 18 | 44 | 2 | 19838193 | ||
| Pubmed | Loss of Prdm12 during development, but not in mature nociceptors, causes defects in pain sensation. | 2.93e-04 | 20 | 44 | 2 | 33789102 | |
| Pubmed | 3.62e-04 | 486 | 44 | 5 | 20936779 | ||
| Pubmed | TNIP1 inhibits selective autophagy via bipartite interaction with LC3/GABARAP and TAX1BP1. | 4.44e-04 | 117 | 44 | 3 | 36898370 | |
| Pubmed | 5.38e-04 | 27 | 44 | 2 | 20301537 | ||
| Pubmed | 5.38e-04 | 27 | 44 | 2 | 23740937 | ||
| Pubmed | Replication of a genome-wide case-control study of esophageal squamous cell carcinoma. | 5.38e-04 | 27 | 44 | 2 | 18649358 | |
| Pubmed | 5.78e-04 | 128 | 44 | 3 | 30995482 | ||
| Pubmed | 6.65e-04 | 30 | 44 | 2 | 20529763 | ||
| Pubmed | 7.11e-04 | 31 | 44 | 2 | 27307491 | ||
| Pubmed | Lem2 is essential for cardiac development by maintaining nuclear integrity. | 7.57e-04 | 32 | 44 | 2 | 37067297 | |
| Pubmed | 7.57e-04 | 32 | 44 | 2 | 19285159 | ||
| Pubmed | 8.06e-04 | 33 | 44 | 2 | 30917309 | ||
| Pubmed | 8.06e-04 | 33 | 44 | 2 | 32140074 | ||
| Pubmed | HAUSP regulates c-MYC expression via de-ubiquitination of TRRAP. | 8.55e-04 | 34 | 44 | 2 | 25925205 | |
| Pubmed | 9.06e-04 | 35 | 44 | 2 | 30818059 | ||
| Pubmed | Characterization and Genetic Analyses of New Genes Coding for NOD2 Interacting Proteins. | 9.06e-04 | 35 | 44 | 2 | 27812135 | |
| Pubmed | Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. | 9.15e-04 | 342 | 44 | 4 | 23128233 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | 9.54e-04 | 910 | 44 | 6 | 36736316 | |
| Pubmed | ZNF212 promotes genomic integrity through direct interaction with TRAIP. | 1.01e-03 | 37 | 44 | 2 | 36594163 | |
| Pubmed | 1.07e-03 | 38 | 44 | 2 | 23273568 | ||
| Pubmed | 1.07e-03 | 1285 | 44 | 7 | 35914814 | ||
| Pubmed | 1.08e-03 | 159 | 44 | 3 | 30581152 | ||
| Pubmed | 1.10e-03 | 622 | 44 | 5 | 14574404 | ||
| Pubmed | 1.11e-03 | 360 | 44 | 4 | 33111431 | ||
| Pubmed | A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway. | 1.14e-03 | 162 | 44 | 3 | 14743216 | |
| Cytoband | 1q24.3 | 1.69e-04 | 20 | 44 | 2 | 1q24.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr14q23 | 2.70e-04 | 130 | 44 | 3 | chr14q23 | |
| Cytoband | 14q23.1 | 9.44e-04 | 47 | 44 | 2 | 14q23.1 | |
| Cytoband | 6q21 | 3.87e-03 | 96 | 44 | 2 | 6q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q23 | 5.68e-03 | 117 | 44 | 2 | chr5q23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6q21 | 6.06e-03 | 121 | 44 | 2 | chr6q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q24 | 6.86e-03 | 129 | 44 | 2 | chr1q24 | |
| GeneFamily | Spectrin repeat containing nuclear envelope family | 1.19e-05 | 4 | 26 | 2 | 1252 | |
| GeneFamily | EF-hand domain containing|Plakins | 5.54e-05 | 8 | 26 | 2 | 939 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 3.63e-05 | 311 | 43 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.26e-08 | 199 | 44 | 6 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Epcam____kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-06 | 184 | 44 | 5 | c86ed59fed687cdaaf7e9c4418d2e3e2c4111cca | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-06 | 184 | 44 | 5 | 7c256bcfa07c5ff55aad0833e8712b0456b5832b | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.45e-06 | 197 | 44 | 5 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.56e-06 | 200 | 44 | 5 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | COVID-19_Moderate-MAIT|World / disease group, cell group and cell class | 1.87e-05 | 160 | 44 | 4 | bf73c5fe87c1f243edec17d7a2c30fae5e2cfd6b | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 1.97e-05 | 162 | 44 | 4 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.43e-05 | 171 | 44 | 4 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-kidney_proximal_straight_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.97e-05 | 180 | 44 | 4 | b34d933cdabf692f02eaaf65c2aaca1fb9510627 | |
| ToppCell | droplet-Kidney-nan-18m|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.23e-05 | 184 | 44 | 4 | e02859bbac36dbbd55d7ae8cb5e46b764d7c6381 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Epcam____kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.30e-05 | 185 | 44 | 4 | 3e3217c99719fd1d2fa94e16be7712a7e5077152 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.30e-05 | 185 | 44 | 4 | 0ff4148b4701003d9d594e0da8261176fb13aa59 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.59e-05 | 189 | 44 | 4 | 0e8d1be3c406d1a393e18faccfe89116a8f82bcf | |
| ToppCell | ILEUM-non-inflamed-(1)_T_cell-(1)_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.59e-05 | 189 | 44 | 4 | 2c8a2fb76ea002bac554bc1c761ce960b5e116e1 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_T_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.90e-05 | 193 | 44 | 4 | a594f89a18273797506287d9e22f72abe53e4920 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.98e-05 | 194 | 44 | 4 | 9588a9b4baebbae08e13d201d4b9dfcf0e6521fb | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.06e-05 | 195 | 44 | 4 | 53528e5788083bce5a8d4611ab3808878e6a9cd3 | |
| ToppCell | Healthy-CD4+_CTL|Healthy / disease group, cell group and cell class | 4.14e-05 | 196 | 44 | 4 | 9da0ea4ad84d6e20e4349d3d1a8cc4d61d08c84f | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.22e-05 | 197 | 44 | 4 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.22e-05 | 197 | 44 | 4 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | LPS_only-Epithelial_alveolar|LPS_only / Treatment groups by lineage, cell group, cell type | 4.30e-05 | 198 | 44 | 4 | 655df75b9692d815c7f6910275e1f684ac63bf62 | |
| ToppCell | Healthy_donor|World / disease group, cell group and cell class (v2) | 4.30e-05 | 198 | 44 | 4 | 1ed0b50c9754727a05c27b21f3546bf2e37eef7f | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type | 4.30e-05 | 198 | 44 | 4 | 85f424cd9bb3117c9e322031024aabb87696ce47 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.30e-05 | 198 | 44 | 4 | 4633e379893a26a746f8e29302cc54bbe04dd23f | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-T_lymphocytic-naive_thymus-derived_CD8-positive,_alpha-beta_T_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.39e-05 | 199 | 44 | 4 | db05c16d80f5a74bfa048a5c92917d312d26f769 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 4.48e-05 | 200 | 44 | 4 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.48e-05 | 200 | 44 | 4 | 73b91cb66c375b44e852404a4a445cf2b9595aee | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.48e-05 | 200 | 44 | 4 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK|COVID-19_Severe / Disease, condition lineage and cell class | 4.48e-05 | 200 | 44 | 4 | 323cb89add511fbe9896b4df0f1f2b7fdbb6c649 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK|COVID-19_Severe / Disease group, lineage and cell class | 4.48e-05 | 200 | 44 | 4 | 9fc818bf5c9133fc2fece47980e71fd3f8603558 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.48e-05 | 200 | 44 | 4 | f1c8780d64b58b6fb84fffbc27f0ad337b1a6e56 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 2.32e-04 | 121 | 44 | 3 | 19333a660800b583fa27b495c1f7828e6636a257 | |
| ToppCell | Epithelial-Epithelial-D_(Clara-Club_cells)|Epithelial / shred on cell class and cell subclass (v4) | 2.43e-04 | 123 | 44 | 3 | caa1576f1b5eb592d522be61c090ac444e277ac5 | |
| ToppCell | TCGA-Peripheral_Nervous_System-Primary_Tumor-Paraganglioma-Paraganglioma-3|TCGA-Peripheral_Nervous_System / Sample_Type by Project: Shred V9 | 3.20e-04 | 135 | 44 | 3 | ac20133d4a36f48338b45bffb13e842cb66f83ad | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 3.20e-04 | 135 | 44 | 3 | ae2d3a42e567b5bade304c0caa497eb725be3565 | |
| ToppCell | ILEUM-non-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.20e-04 | 135 | 44 | 3 | b7a792a7c0c22d8b703509f134115f0e394d7de0 | |
| ToppCell | Healthy-CD4+_T_activated|World / disease group, cell group and cell class | 3.56e-04 | 140 | 44 | 3 | 407691970ec72a3afb45e431cf48814546b8acff | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Stem_cells|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 3.78e-04 | 143 | 44 | 3 | 0118772a5bc7c48465e9b314be55203412e8d67c | |
| ToppCell | AT1-AT2_cells-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 3.94e-04 | 145 | 44 | 3 | cd5de30fd948024e3ad043c9411ce9f2722178b2 | |
| ToppCell | Healthy-CD4+_T_activated|Healthy / disease group, cell group and cell class | 3.94e-04 | 145 | 44 | 3 | 45e8089fdf7d6f69b383816d8945e39fba24c873 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 4.10e-04 | 147 | 44 | 3 | 94998bc40f5c08295cfe3bdcbe43f13b1e564b3d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.35e-04 | 150 | 44 | 3 | 8645b9c7f9511ed6cc9afe04440c2873a3094150 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_3|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 4.97e-04 | 157 | 44 | 3 | 6a0aa66964eecbbc232abf1d2e6c8422e4ce69d0 | |
| ToppCell | Leuk-UTI-Lymphocyte-T_NK-gdT|Leuk-UTI / Disease, Lineage and Cell Type | 5.06e-04 | 158 | 44 | 3 | c4b0af25608cee3d0d2b0193f5ff45d9dc87078b | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.35e-04 | 161 | 44 | 3 | 22fea192cd5f6d3544533d8b10e1d74dfedf0f05 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.64e-04 | 164 | 44 | 3 | f6a961fa2002da7d9679f32af99e1314c0593ef9 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c04-COTL1|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.95e-04 | 167 | 44 | 3 | 3b717d33aaf1ef0869cc4bca8432ba8008875cc5 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.05e-04 | 168 | 44 | 3 | b94b1f37c92e019d01ecfa3b7cc6797b6e4a56ff | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 6.05e-04 | 168 | 44 | 3 | 2fb2d916eb5000a637240d38e47a9b4f61f9f83f | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.59e-04 | 173 | 44 | 3 | c63a615998d13b1725b5767f4ad2ec7e2b61db68 | |
| ToppCell | mild_COVID-19_(asymptomatic)-gd_T|World / disease group, cell group and cell class (v2) | 6.59e-04 | 173 | 44 | 3 | b6615ff02f5017d7150b1e33b53f8c7a26081a0d | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.81e-04 | 175 | 44 | 3 | cf53a15bfb37b6019e7052ffdf594a9ac040900e | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-T_mait-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.81e-04 | 175 | 44 | 3 | cc2428150987911d0d382e8177918724aa69f85c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.93e-04 | 176 | 44 | 3 | 5914e7635474e7cf24d446bdb1423bc0807ee9c6 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.93e-04 | 176 | 44 | 3 | 1595dbeee336a81e581325d63208ec6262664ee9 | |
| ToppCell | 10x5'-lymph-node_spleen-Hematopoietic_progenitors-HSC-MPP|lymph-node_spleen / Manually curated celltypes from each tissue | 6.93e-04 | 176 | 44 | 3 | de67ed15a50d2515ba6d152c1011a3367f77aedd | |
| ToppCell | Int-URO-Lymphocyte-T_NK-gdT|Int-URO / Disease, Lineage and Cell Type | 6.93e-04 | 176 | 44 | 3 | 15016a73c953d8d3e7c32a05ead5e7261f9914ca | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-T_mait|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.93e-04 | 176 | 44 | 3 | 003076f1a983409ddf31b9c19e61c1facdd72566 | |
| ToppCell | facs-Kidney-nan-18m-Epithelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.04e-04 | 177 | 44 | 3 | 7f58286fc8797e9bdcf8ece0849f55680905955d | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.16e-04 | 178 | 44 | 3 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.16e-04 | 178 | 44 | 3 | 15a99080e9f669572ab6d82934f324e6714846c1 | |
| ToppCell | Control-Lymphocyte-T_NK-CD4_CTL|Control / Disease, Lineage and Cell Type | 7.16e-04 | 178 | 44 | 3 | 32fbb7a8d7daa7cb37f42923514acbb9090e6811 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.16e-04 | 178 | 44 | 3 | 200308e109abb7e6f8816a6f8cce6d56862d4098 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.39e-04 | 180 | 44 | 3 | f8bdfd7bf7b3d52c659a29d8f5f80858e79da83e | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_B-Branch_B2_(eMN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.39e-04 | 180 | 44 | 3 | 368ff7fcfd21ad248f96a83a8b191040ba7d8670 | |
| ToppCell | AT1-AT2_cells-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 7.51e-04 | 181 | 44 | 3 | ca23ce4f2c7b684d8ddd0e8619b3b696023d75e3 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.51e-04 | 181 | 44 | 3 | 566249e04dd491e6287ad2101b7b1ab11031ed8b | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.51e-04 | 181 | 44 | 3 | 9542c19edc9bd2cba68c01c2a8407705398e3011 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.51e-04 | 181 | 44 | 3 | 8f04f8cac5d705dc5f6cf6f4516d6e45b0aa4ae5 | |
| ToppCell | facs-Kidney-nan-18m-Epithelial-kidney_collecting_duct_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.51e-04 | 181 | 44 | 3 | bec7076efe94898213a62db72d171d737949977e | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 7.51e-04 | 181 | 44 | 3 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.51e-04 | 181 | 44 | 3 | db9528dc7cb0230e4c36cb27da69102c588c7ee9 | |
| ToppCell | facs-Kidney-nan-18m-Epithelial-kidney_collecting_duct_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.51e-04 | 181 | 44 | 3 | cf149b30b814cf87c9e923ef502cadf7fe4a3597 | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.75e-04 | 183 | 44 | 3 | 983ca1342ddd365e1f1df32a456394b002b10e41 | |
| ToppCell | normal-na-Lymphocytic_T-CytoT_GZMK+-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 7.75e-04 | 183 | 44 | 3 | 79defd22b3194dad16db55b9bdd220c09c1e6b90 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 7.75e-04 | 183 | 44 | 3 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.88e-04 | 184 | 44 | 3 | 45577ff91c3b2b303acd97239dde2463ea7a429c | |
| ToppCell | (1)_T_cells-(1)_T_regulatory|(1)_T_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 7.88e-04 | 184 | 44 | 3 | 3cbf81757653652441843d85cb7ec1dcf25ca1b0 | |
| ToppCell | Healthy/Control-CD4+_CTL|Healthy/Control / Disease group and Cell class | 7.88e-04 | 184 | 44 | 3 | 6c6ffa150f81e456f88e9065de90c2dcda417589 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Epcam____kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.88e-04 | 184 | 44 | 3 | 3d7dd193a0826cc7a4e454a29236a16c315e5965 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 8.00e-04 | 185 | 44 | 3 | 406b52516b26e9fe2c9e768950af447ec7ad5f3e | |
| ToppCell | normal-na-Lymphocytic_T-CytoT_GZMH+-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 8.00e-04 | 185 | 44 | 3 | 097d628f92e13250c15b550f2fd1f4225fc07558 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 8.00e-04 | 185 | 44 | 3 | f2ebd099c8dfcfaca4298bcdd618c50701a9c2c8 | |
| ToppCell | mild_COVID-19_(asymptomatic)-gd_T|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 8.13e-04 | 186 | 44 | 3 | 5fa3ed834898aa06aae15a8ade7ab93a6e4744f8 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-CD8+_T_activated|COVID-19_Severe / Disease group, lineage and cell class | 8.25e-04 | 187 | 44 | 3 | 4c4c4406e16a15dedcd50bbcc2059d722a2e3d2c | |
| ToppCell | Control-Lymphocyte-T_NK-CD8_TEM|Control / Disease, Lineage and Cell Type | 8.25e-04 | 187 | 44 | 3 | 7fdff970a9397305d0b8194c00a043cc69dcca12 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.25e-04 | 187 | 44 | 3 | 236e9857729670e87eed30fad58f49e1f56e4a85 | |
| ToppCell | Healthy/Control-CD4+_CTL|World / Disease group and Cell class | 8.25e-04 | 187 | 44 | 3 | d54d3214d77a9469e94a16c00a80626fd4953e2b | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 8.25e-04 | 187 | 44 | 3 | 0099def970fbc828756fbf853eca2ce77b8cd342 | |
| ToppCell | mild_COVID-19-CD4+_CTL|mild_COVID-19 / disease group, cell group and cell class (v2) | 8.25e-04 | 187 | 44 | 3 | 49196d07e4716c87d33229a4569bdb6b4613b3eb | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-NK_dim-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 8.25e-04 | 187 | 44 | 3 | 0bca79cea4886b66350c56c61859bd71e1e7a85c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell-T_gdT_c14-TRDV2|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.38e-04 | 188 | 44 | 3 | f8e6247bedc0ba494c5bb551539cb8ba5a97f557 | |
| ToppCell | facs-MAT-Fat-3m|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.38e-04 | 188 | 44 | 3 | 7da9750255efbc5cf9aed7e3105a337fac63b9f0 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 8.38e-04 | 188 | 44 | 3 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD8-Trm/em_CD8|blood / Manually curated celltypes from each tissue | 8.38e-04 | 188 | 44 | 3 | 21730497f95dc271e4cdfaaf1da8b9ac6eec2ded | |
| ToppCell | facs-Kidney-nan-3m-Epithelial-kidney_collecting_duct_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.38e-04 | 188 | 44 | 3 | c1f64311ff05093b2f4f672e33f5f75e3bc8a8db | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.38e-04 | 188 | 44 | 3 | 8155bc5476fc333bedcc78c5ddcc8e4912536caa | |
| ToppCell | facs-Kidney-nan-3m-Epithelial-kidney_collecting_duct_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.38e-04 | 188 | 44 | 3 | b483b4629695764568bcbd1d527d614824147783 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_T-CytoT_GZMK+-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 8.38e-04 | 188 | 44 | 3 | 2513ca0efa73c09a3406b99e2876982d78b173d7 | |
| ToppCell | Epithelial-Epithelial-D_(Ciliated)|Epithelial / shred on cell class and cell subclass (v4) | 8.38e-04 | 188 | 44 | 3 | 8f30535a32968a81a304315a49c0d90a77d36948 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.48e-04 | 49 | 23 | 3 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.57e-04 | 50 | 23 | 3 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_4 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.57e-04 | 50 | 23 | 3 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_UNASSIGNED_1 | |
| Drug | TCVC | 5.61e-07 | 9 | 44 | 3 | CID000108091 | |
| Drug | p-tolyl sulfoxide | 1.46e-06 | 12 | 44 | 3 | CID000015680 | |
| Disease | Autosomal dominant Emery-Dreifuss muscular dystrophy | 1.30e-05 | 4 | 44 | 2 | cv:CN293514 | |
| Disease | Autosomal Recessive Emery-Dreifuss Muscular Dystrophy | 2.17e-05 | 5 | 44 | 2 | C1450051 | |
| Disease | Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder) | 2.17e-05 | 5 | 44 | 2 | C0410190 | |
| Disease | Emery-Dreifuss muscular dystrophy | 3.25e-05 | 6 | 44 | 2 | cv:C0410189 | |
| Disease | Muscular Dystrophy, Emery-Dreifuss | 3.25e-05 | 6 | 44 | 2 | C0410189 | |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 4.54e-05 | 7 | 44 | 2 | C0751337 | |
| Disease | Psoriasis | 8.56e-05 | 57 | 44 | 3 | C0033860 | |
| Disease | Pustulosis of Palms and Soles | 8.56e-05 | 57 | 44 | 3 | C0030246 | |
| Disease | unipolar depression, bipolar disorder | 8.65e-05 | 156 | 44 | 4 | EFO_0003761, MONDO_0004985 | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 1.42e-04 | 12 | 44 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | Methionine sulfoxide measurement | 1.42e-04 | 12 | 44 | 2 | EFO_0021650 | |
| Disease | level of Sphingomyelin (d32:1) in blood serum | 2.91e-04 | 17 | 44 | 2 | OBA_2045173 | |
| Disease | multiple myeloma | 6.29e-04 | 112 | 44 | 3 | EFO_0001378 | |
| Disease | systemic scleroderma, systemic lupus erythematosus | 6.90e-04 | 26 | 44 | 2 | EFO_0000717, MONDO_0007915 | |
| Disease | psoriasis | 7.27e-04 | 273 | 44 | 4 | EFO_0000676 | |
| Disease | visceral heterotaxy (implicated_via_orthology) | 1.40e-03 | 37 | 44 | 2 | DOID:0050545 (implicated_via_orthology) | |
| Disease | sex interaction measurement, Crohn's disease | 1.40e-03 | 37 | 44 | 2 | EFO_0000384, EFO_0008343 | |
| Disease | systemic scleroderma, rheumatoid arthritis, myositis, systemic lupus erythematosus | 1.48e-03 | 38 | 44 | 2 | EFO_0000685, EFO_0000717, EFO_0000783, MONDO_0007915 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QMQHWKEQRAAQKAD | 11 | P04040 | |
| SNAEQDDLWRHFQMA | 536 | Q6Q4G3 | |
| KQLWMGLQNDRFDQF | 151 | Q9H1Y0 | |
| NNKGWHSMVAFVNRA | 1476 | Q8IZY2 | |
| GSYEAMMDDQNHNNW | 11 | Q86Y37 | |
| RQGHSNFKQMQELNW | 1086 | Q6ZRR7 | |
| FSNKSANMDHWQQRF | 206 | Q9NZL9 | |
| AYDNWNEQRMALHKD | 3291 | Q2LD37 | |
| NNMGAHEEKKEDWNN | 816 | Q8NCM2 | |
| AHQEALKMEWQNFLN | 261 | A8MZ36 | |
| AHQEALKMEWQNFLN | 306 | Q92817 | |
| KNNNLMWEVFNEDGT | 131 | Q9H4Q4 | |
| DNGRNFDKNGNMMDW | 621 | Q495T6 | |
| MQQSKNQSADHRAAW | 356 | Q9Y6M4 | |
| EQDNGWKSMSQEHLN | 341 | Q8NFU5 | |
| NNFFIWNLQHDPMGK | 461 | Q8TCU5 | |
| DGWAFKNNMDIRNHQ | 161 | P49895 | |
| ERKWQHLEQNNFAMK | 546 | Q96LB3 | |
| QNKFHEERQMAWDQR | 1396 | O15078 | |
| MERKINNWLNHANYG | 256 | Q01740 | |
| IEQQMNRWFNHENYG | 256 | Q99518 | |
| WKSSHFERRDNMNDN | 531 | P05060 | |
| RHFNINNLDNNWLKM | 296 | Q8IZU8 | |
| NNQAMKGRFEELSAW | 61 | Q96CV9 | |
| NQDYWLQMAVGANDH | 346 | O75818 | |
| WQDAHLGKDQRDFNM | 846 | O95602 | |
| MVHEGNQRWDNLQKR | 8081 | Q8NF91 | |
| KQMVHEGNQRWDNLQ | 6216 | Q8WXH0 | |
| NFTNEKLQQFFNWHM | 491 | Q9Y2K3 | |
| DGQKLRDAFTWNMNE | 196 | Q12824 | |
| REMQNLSQHGRKNNW | 106 | O15126 | |
| WNLVFMQHNREADGS | 241 | Q5JTZ9 | |
| AEHQFSFMEKRNQWL | 136 | O43734 | |
| VNKQWDQHFRSMKQQ | 316 | Q15025 | |
| QNREFMVFAHAQWKA | 86 | Q9HAW8 | |
| KMGQEHSLFFNNNNW | 231 | Q8N801 | |
| KDGMDNNHNWNTHGD | 141 | Q8TAQ9 | |
| NHGNFQGDSNFNRMW | 76 | Q8TF01 | |
| DDLGRWHQKNAMNLN | 246 | O43247 | |
| WFLNQVRSKDQHAMG | 1031 | Q70CQ2 | |
| IWHDNMQFLQDKNIF | 2261 | Q70CQ2 | |
| QHMEGTQINQSEKWN | 76 | Q7Z2W7 | |
| FQERHRKENMAATNW | 1676 | Q9Y4A5 | |
| IGMKWENQNIDDQHQ | 91 | P15621 | |
| KAMASLQNERDHLWN | 2836 | Q14789 | |
| FDWGNSDQNMMHFHQ | 306 | Q5VXJ0 | |
| LGDAHDWNQNRAKQA | 451 | Q92802 |